Pharmacogenetic DNA Bank
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Cancer
Both
Cancer
Trial Information
Pharmacogenetic DNA Bank
Inclusion Criteria:
- Any cancer patient who is aged >=18 is eligible.
Exclusion Criteria:
- Cancer patients who are below age 18 will be excluded.
Type of Study:
Observational
Study Design:
Observational Model: Case-Crossover, Time Perspective: Cross-Sectional
Principal Investigator
Soo Chin Lee, MBBS, MRCP
Investigator Role:
Principal Investigator
Investigator Affiliation:
National University Hospital, Singapore
Authority:
Singapore: Domain Specific Review Boards
Study ID:
PG01/02/09
NCT ID:
NCT00941200
Start Date:
April 2009
Completion Date:
Related Keywords:
- Cancer
Name | Location |
|---|
